ACM
GILD icon

Atika Capital Management’s Gilead Sciences GILD Stock Holding History

Atika Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-52,100
Closed -$3.91M – 64
2013
Q4 		$3.91M Buy
+52,100
New +$3.63M 3.48% 7

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Atika Capital Management's GILD Position: Q1 2014 in Review

Atika Capital Management sold out of Gilead Sciences (GILD) in Q1 2014, closing a stake of 52,100 shares — an estimated $3.91M sold.

Atika Capital Management first reported a position in GILD in Q4 2013 and held it in 1 quarter. The position peaked at $3.91M in Q4 2013. 1,188 funds tracked by Wall St. Rank hold GILD as of Q1 2014.

  • Atika Capital Management reported no remaining Gilead Sciences position as of Q1 2014 after selling out during the quarter.
  • Atika Capital Management sold 52,100 Gilead Sciences shares in Q1 2014, an estimated $3.91M.
  • Atika Capital Management first reported a position in Gilead Sciences in Q4 2013 and held it in 1 quarter.
  • Atika Capital Management's Gilead Sciences position peaked at $3.91M in Q4 2013.
  • 1,188 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2014.

Based on Atika Capital Management's 13F filing for Q1 2014, filed 15 May 2014.